Patent · US Active

Method for transdermal iontophoretic delivery of chelated agents

US8821945B2 · kind B2 · utility

6Cited by
46References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2009
Grant dateSep 2, 2014
Priority date
Expiry dateDec 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/703
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.